期刊文献+

Chronic lymphocytic leukemia in China

原文传递
导出
摘要 Chronic lymphocytic leukemia(CLL)is 10-to 20-fold less common in Han Chinese in China compared with persons of predominately European descent translating to inci-dences of 0.2 to 0.6 per 10E+5 population/year vs.4.6 per 10E+5 population/year.[1-3] Reason(s)for this markedly lower incidence and therefore prevalence in China is unknown but is shared with the other Asian nationalities including.Japanese,Koreans,and others,.+-61 Studies of large cohorts of Chinese with CLL are relatively rare and there are no population-based studies in the mainland of China.Several seeming differences between CLL in Chinese and persons of predominately European descent are reported such as younger age at diagnosis,different background genotypes,increased frequency of IGHV mutation,different stereotype use and different mutation topographies.7 However,in general,most cases of CLL in Han Chinese are like CLL in persons of predominately European descent.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2022年第8期883-886,共4页 中华医学杂志(英文版)
基金 RPG acknowledges support from the National Institute of Health Research (NIHR) Biomedical Research Centre funding scheme.
  • 相关文献

参考文献2

二级参考文献30

  • 1Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines. Blood 2008; 111: 5446-5456.
  • 2Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-1916.
  • 3Mayr C, Speicher MR, Kofler DM, Buhmann R, Strehl J, Busch R, et al. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 2006; 107: 742-751.
  • 4Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, et al. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003; 121: 287-295.
  • 5Nelson BP, Gupta R, Dewald GW, Paternoster SF, Rosen ST, Peterson LC. Chronic lymphocytic leukemia FISH panel: impact on diagnosis. Am J Clin Pathol 2007; 128: 323-332.
  • 6Glassman AB, Hayes KJ. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet 2005; 158: 88-91.
  • 7Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410-1416.
  • 8Oscier DG, Gardiner AC, Mould S J, Glide S, Davis ZA, Ibbotson RE, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177-1184.
  • 9Durak B, Akay OM, Asian V, Ozdemir M, Sahin F, Artan S, et al. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 2009; 188: 65-69.
  • 10Nowakowski GS, Dewald GW, Hoyer JD, Patemoster SF, Stockero K J, Fink SR, et al. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol 2005; 130: 36-42.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部